Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease
Crossref DOI link: https://doi.org/10.1186/s40661-015-0013-2
Published Online: 2015-08-28
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castro, Michael P.
Whitcomb, Bradford P.
Zajchowski, Deborah A.
Coleman, Robert L.
Text and Data Mining valid from 2015-05-01
Article History
Received: 1 June 2015
Accepted: 18 August 2015
First Online: 28 August 2015